Pregnenolone sulfate induces NMDA receptor dependent release of dopamine from synaptic terminals in the striatum

Journal of Neurochemistry

Volumn 107, Issue 2, 2008, Pages 510-521

  Whittaker, Matthew T ^a   Gibbs, Terrell T ^a   Farb, David H ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Neuroactive steroid; NMDA receptors; Striatum; Superfusion; Synaptoneurosome; Synaptosome

Indexed keywords

4 AMINOBUTYRIC ACID; DOPAMINE; DOPAMINE TRANSPORTER; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PREGNENOLONE SULFATE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; DRUG MECHANISM; MALE; NERVE ENDING; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; RAT; SYNAPSE VESICLE; SYNAPTOSOME;

6-CYANO-7-NITROQUINOXALINE-2,3-DIONE; ANIMALS; CORPUS STRIATUM; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID AGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; GLUTAMIC ACID; GLYCINE; MALE; MICROSCOPY, ELECTRON, SCANNING; N-METHYLASPARTATE; POTASSIUM CHLORIDE; PREGNENOLONE; PRESYNAPTIC TERMINALS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; SYNAPTOSOMES; TRITIUM; VALINE;

RATTUS;

EID: 53149096982     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2008.05627.x     Document Type: Article

References (54)

1. Barrot M., Vallee M., Gingras M. A., Le Moal M., Mayo W. Piazza P. V. (1999) The neurosteroid pregnenolone sulphate increases dopamine release and the dopaminergic response to morphine in the rat nucleus accumbens. Eur. J. Neurosci. 11, 3757 3760.
2. Becker J. B. (1990) Direct effect of 17 beta-estradiol on striatum: sex differences in dopamine release. Synapse 5, 157 164.
3. Bernard V. Bolam J. P. (1998) Subcellular and subsynaptic distribution of the NR1 subunit of the NMDA receptor in the neostriatum and globus pallidus of the rat: co-localization at synapses with the GluR2/3 subunit of the AMPA receptor. Eur. J. Neurosci. 10, 3721 3736.
4. Bukusoglu C. Sarlak F. (1996) Pregnenolone sulfate increases intracellular Ca2+ in a pituitary cell line. Eur. J. Pharmacol. 298, 79 85.
5. Chang M., Peng K. W., Kastrati I., Overk C. R., Qin Z. H., Yao P., Bolton J. L. Thatcher G. R. (2007) Activation of estrogen receptor-mediated gene transcription by the equine estrogen metabolite, 4-methoxyequilenin, in human breast cancer cells. Endocrinology 148, 4793 4802.
6. Clow D. W. Jhamandas K. (1989) Characterization of L-glutamate action on the release of endogenous dopamine from the rat caudate-putamen. J. Pharmacol. Exp. Ther. 248, 722 728.
7. Compagnone N. A., Salido E., Shapiro L. J. Mellon S. H. (1997) Expression of steroid sulfatase during embryogenesis. Endocrinology 138, 4768 4773.
8. Dong Y., Fu Y. M., Sun J. L., Zhu Y. H., Sun F. Y. Zheng P. (2005) Neurosteroid enhances glutamate release in rat prelimbic cortex via activation of alpha1-adrenergic and sigma1 receptors. Cell. Mol. Life Sci. 62, 1003 1014.
9. Dunkley P. R., Heath J. W., Harrison S. M., Jarvie P. E., Glenfield P. J. Rostas J. A. (1988) A rapid Percoll gradient procedure for isolation of synaptosomes directly from an S1 fraction: homogeneity and morphology of subcellular fractions. Brain Res. 441, 59 71.
10. Ebner M. J., Corol D. I., Havlíková H., Honour J. W. Fry J. P. (2006) Identification of neuroactive steroids and their precursors and metabolites in adult male rat brain. Endocrinology 147, 179 190.
11. Farb D. H. Gibbs T. T. (1996) Steroids as modulators of amino acid receptor function, in CNS Transmitters and Neuromodulators: Neuroactive Steroids (Stone T. W., ed pp. 23 36. CRC Press, New York.
12. Foy M. R., Xu J., Xie X., Brinton R. D., Thompson R. F. Berger T. W. (1999) 17beta-estradiol enhances NMDA receptor-mediated EPSPs and long-term potentiation. J. Neurophysiol. 81, 925 929.
13. Gibbs T. T. Farb D. H. (2000) Dueling enigmas: neurosteroids and sigma receptors in the limelight. Sci. STKE 2000, PE1.
14. Gibbs T. T., Russek S. J. Farb D. H. (2006) Sulfated steroids as endogenous neuromodulators. Pharmacol. Biochem. Behav. 84, 555 567.
15. Gracy K. N., Clarke C. L., Meyers M. B. Pickel V. M. (1999) N-methyl-D-aspartate receptor 1 in the caudate-putamen nucleus: ultrastructural localization and co-expression with sorcin, a 22,000 mol. wt calcium binding protein. Neuroscience 90, 107 117.
16. Graybiel A. M. (2000) The basal ganglia. Curr. Biol. 10, R509 R511.
17. Hayashi T., Maurice T. Su T. P. (2000) Ca⊃2ζ signaling via σ-receptors: novel regulatory mechanism affecting intracellular Ca⊃2ζ concentration. J. Pharmacol. Exp. Ther. 293, 788 798.
18. Hige T., Fujiyoshi Y. Takahashi T. (2006) Neurosteroid pregnenolone sulfate enhances glutamatergic synaptic transmission by facilitating presynaptic calcium currents at the calyx of Held of immature rats. Eur. J. Neurosci. 24, 1955 1966.
19. Hojo Y., Hattori T. A., Enami T. et al. (2004) Adult male rat hippocampus synthesizes estradiol from pregnenolone by cytochromes P45017alpha and P450 aromatase localized in neurons. Proc. Natl Acad. Sci. USA 101, 865 870.
20. Ito K., Skinkle K. L. Hicks T. P. (1999) Age-dependent, steroid-specific effects of oestrogen on long-term potentiation in rat hippocampal slices. J. Physiol. 515, 209 220.
21. Johansson T., Frändberg P. A., Nyberg F. Le Grevès P. (2008) Molecular mechanisms for nanomolar concentrations of neurosteroids at NR1/NR2B receptors. J. Pharmacol. Exp. Ther. 324, 759 768.
22. Johnson K. M. Jeng Y. J. (1991) Pharmacological evidence for N-methyl-D-aspartate receptors on nigrostriatal dopaminergic nerve terminals. Can. J. Physiol. Pharmacol. 69, 1416 1421.
23. Kohjitani A., Fuda H., Hanyu O. Strott C. A. (2006) Cloning, characterization and tissue expression of rat SULT2B1a and SULT2B1b steroid/sterol sulfotransferase isoforms: divergence of the rat SULT2B1 gene structure from orthologous human and mouse genes. Gene 367, 66 73.
24. Kohjitani A., Fuda H., Hanyu O. Strott C. A. (2008) Regulation of SULT2B1a (pregnenolone sulfotransferase) expression in rat C6 glioma cells: relevance of AMPA receptor-mediated NO signaling. Neurosci. Lett. 430, 75 80.
25. Konradi C. Heckers S. (2003) Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment. Pharmacol. Ther. 97, 153 179.
26. Kow L. M., Easton A. Pfaff D. W. (2005) Acute estrogen potentiates excitatory responses of neurons in rat hypothalamic ventromedial nucleus. Brain Res. 1043, 124 131.
27. Krebs M. O., Desce J. M., Kemel M. L., Gauchy C., Godeheu G., Cheramy A. Glowinski J. (1991) Glutamatergic control of dopamine release in the rat striatum: evidence for presynaptic N-methyl-D-aspartate receptors on dopaminergic nerve terminals. J. Neurochem. 56, 81 85.
28. Lanthier A. Patwardhan V. V. (1986) Sex steroids and 5-en-3 beta-hydroxysteroids in specific regions of the human brain and cranial nerves. J. Steroid. Biochem. 25, 445 449.
29. Liere P., Pianos A., Eychenne B., Cambourg A., Liu S., Griffiths W., Schumacher M., Sjövall J. Baulieu E. E. (2004) Novel lipoidal derivatives of pregnenolone and dehydroepiandrosterone and absence of their sulfated counterparts in rodent brain. J. Lipid Res. 45, 2287 2302.
30. Malayev A. A., Gibbs T. T. Farb D. H. (2002) Inhibition of the NMDA Response by pregnenolone sulfate reveals subtype selective modulation of NMDA receptors by sulfated steroids. Br. J. Pharmacol. 135, 901 909.
31. Mameli M., Carta M., Partridge L. D. Valenzuela C. F. (2005) Neurosteroid-induced plasticity of immature synapses via retrograde modulation of presynaptic NMDA receptors. J. Neurosci. 25, 2285 2294.
32. Mathis C., Vogel E., Cagniard B., Criscuolo F. Ungerer A. (1996) The neurosteroid pregnenolone sulfate blocks deficits induced by a competitive NMDA antagonist in active avoidance and lever-press learning tasks in mice. Neuropharmacology 35, 1057 1064.
33. Mellon S. H., Griffin L. D. Compagnone N. A. (2001) Biosynthesis and action of neurosteroids. Brain Res. Brain Res. Rev. 37, 3 12.
34. Meyer D. A., Carta M., Partridge L. D., Covey D. F. Valenzuela C. F. (2002) Neurosteroids enhance spontaneous glutamate release in hippocampal neurons. Possible role of metabotropic σ-like receptors. J. Biol. Chem. 277, 28725 28732.
35. Meziane H., Mathis C., Paul S. M. Ungerer A. (1996) The neurosteroid pregnenolone sulfate reduces learning deficits induced by scopolamine and has promnestic effects in mice performing an appetitive learning task. Psychopharmacology (Berl) 126, 323 330.
36. Monnet F. P., Mahe V., Robel P. Baulieu E. E. (1995) Neurosteroids, via σ receptors, modulate the [⊃3H]norepinephrine release evoked by N-methyl-D-aspartate in the rat hippocampus. Proc. Natl Acad. Sci. USA 92, 3774 3778.
37. Morissette M., Garcia-Segura L. M., Belanger A. DiPaolo T. (1992) Changes of rat striatal neuronal membrane morphology and steroid content during the estrous cycle. Neuroscience 49, 893 902.
38. Mukai H., Tsurugizawa T., Murakami G. et al. (2007) Rapid modulation of long-term depression and spinogenesis via synaptic estrogen receptors in hippocampal principal neurons. J. Neurochem. 100, 950 967.
39. Park-Chung M., Wu F., Purdy R. H., Malayev A. A., Gibbs T. T. Farb D. H. (1997) Distinct sites for inverse modulation of NMDA receptors by sulfated steroids. Mol. Pharmacol. 52, 1113 1123.
40. Partridge L. D. Valenzuela C. F. (2001) Neurosteroid-induced enhancement of glutamate transmission in rat hippocampal slices. Neurosci. Lett. 301, 103 106.
41. Pittaluga A., Pattarini R., Feligioni M. Raiteri M. (2001) N-methyl-D-aspartate receptors mediating hippocampal noradrenaline and striatal dopamine release display differential sensitivity to quinolinic acid, the HIV-1 envelope protein gp120, external pH and protein kinase C inhibition. J. Neurochem. 76, 139 148.
42. Plassart-Schiess E. Baulieu E. E. (2001) Neurosteroids: recent findings. Brain Res. Brain Res. Rev. 37, 133 140.
43. Sabeti J., Nelson T. E., Purdy R. H. Gruol D. L. (2007) Steroid pregnenolone sulfate enhances NMDA-receptor-independent long-term potentiation at hippocampal CA1 synapses: role for L-type calcium channels and sigma-receptors. Hippocampus 17, 349 369.
44. Sadri-Vakili G., Janis G., Pierce R., Gibbs T. T. Farb D. H. (2008) Nanomolar concentrations of pregnenolone sulfate enhance striatal dopamine overflow in vivo. J. Pharmacol. Exp. Ther., in press.
45. Saka E. Graybiel A. M. (2003) Pathophysiology of Tourette's syndrome: striatal pathways revisited. Brain Dev. 25 (Suppl 1 S15 S19.
46. Sanz A. G., Hospital S., Badia A. Clos M. V. (2000) Presynaptic effect of 7-OH-DPAT on evoked [3H]acetylcholine release in rat striatal synaptosomes. Brain Res. 874, 116 122.
47. Schiess A. R., Scullin C. S. Partridge L. D. (2006) Neurosteroid-induced enhancement of short-term facilitation involves a component downstream from presynaptic calcium in hippocampal slices. J. Physiol. 576, 833 847.
48. Schumacher M., Liere P., Akwa Y., Rajkowski K., Griffiths W., Bodin K., Sjövall J. Baulieu E. E. (2008) Pregnenolone sulfate in the brain: a controversial neurosteroid. Neurochem. Int. 52, 522 540.
49. Sliwinski A., Monnet F. P., Schumacher M. Morin-Surun M. P. (2004) Pregnenolone sulfate enhances long-term potentiation in CA1 in rat hippocampus slices through the modulation of N-methyl-D-aspartate receptors. J. Neurosci. Res. 78, 691 701.
50. Snell L. D. Johnson K. M. (1986) Characterization of the inhibition of excitatory amino acid-induced neurotransmitter release in the rat striatum by phencyclidine-like drugs. J. Pharmacol. Exp. Ther. 238, 938 946.
51. Tarazi F. I., Campbell A., Yeghiayan S. K. Baldessarini R. J. (1998) Localization of ionotropic glutamate receptors in caudate-putamen and nucleus accumbens septi of rat brain: comparison of NMDA, AMPA, and kainate receptors. Synapse 30, 227 235.
52. Wang J. K. (1991) Presynaptic glutamate receptors modulate dopamine release from striatal synaptosomes. J. Neurochem. 57, 819 822.
53. Wu F. S., Gibbs T. T. Farb D. H. (1991) Pregnenolone sulfate: a positive allosteric modulator at the N-methyl-D-aspartate receptor. Mol. Pharmacol. 40, 333 336.
54. Xiao L., Jackson L. R. Becker J. B. (2003) The effect of estradiol in the striatum is blocked by ICI 182,780 but not tamoxifen: pharmacological and behavioral evidence. Neuroendocrinology 77, 239 245.